Shanghai Shangdao Apricot Spirit Technology Pharmaceutical

Shanghai Shangyao Xingling Technology Pharmaceutical is a prominent Chinese pharmaceutical firm specializing in the modernization of Traditional Chinese Medicine (TCM). As a key subsidiary of Shanghai Pharmaceuticals Holding (SPH), the company focuses on the research, development, and production of natural plant-based medicines, particularly those derived from Ginkgo biloba. Its flagship products, such as Xinglingke, are widely used in China for treating cardiovascular and cerebrovascular conditions. The company is recognized for its advanced extraction and quality control processes, which align with international standards for botanical drugs. It maintains a strong industrial presence with GMP-certified manufacturing facilities in Shanghai and plays a significant role in the natural medicine sector by bridging traditional knowledge with modern pharmaceutical technology.